Table 1. Summary of clinical data of the 39 cases of MFH in the study.
|
Recurrent disease |
End of follow-up |
5-year survival |
||||||
|---|---|---|---|---|---|---|---|---|
| Informative | Rec/Met | DF | DOD | NED | DFS mean | DFS | OAS | |
| Variable | (n=) | (n=) | (n=) | (n=) | (n=) | (months) | (%) | (%) |
| Sex | ||||||||
| Female | 20 | 13 | 7 | 11 | 9 | 36 | 37 | 55 |
| Male | 19 | 10 | 9 | 8 | 11 | 45 | 45 | 55 |
| Malignancy grade | ||||||||
| Grade III | 14 | 10 | 4 | 6 | 8 | 35 | 34 | 59 |
| Grade IV | 25 | 13 | 12 | 13 | 12 | 40 | 44 | 50 |
| Depth | ||||||||
| Intramuscular | 15 | 10 | 5 | 9 | 6 | 32 | 32 | 43 |
| Subcutaneous | 9 | 2 | 7 | 0 | 9 | — | 66 | 70 |
| Extracompartmental | 12 | 8 | 4 | 7 | 5 | 33 | 23 | 43 |
| Size (cm) | ||||||||
| >8 | 19 | 15 | 4 | 13 | 6 | 24 | 18 | 36 |
| ⩽8 | 19 | 7 | 12 | 5 | 14 | — | 66 | 72 |
| Surgical margin | ||||||||
| Wide | 18 | 10 | 8 | 7 | 11 | 46 | 43 | 58 |
| Marginal | 10 | 4 | 6 | 3 | 7 | — | 57 | 65 |
| Intralesional | 7 | 5 | 2 | 5 | 2 | 26 | 14 | 29 |
| Site | ||||||||
| Upper extremity | 3 | 2 | 1 | 1 | 2 | — | 17 | 19 |
| Lower extremity | 24 | 14 | 10 | 12 | 12 | 36 | 38 | 58 |
| Trunk | 7 | 4 | 3 | 4 | 3 | 16 | 23 | 32 |
| Pelvis | 5 | 3 | 2 | 2 | 3 | — | 19 | 24 |
| Age at diagnosis (years) | ||||||||
| >60 | 26 | 13 | 13 | 11 | 15 | 69 | 52 | 60 |
| ⩽60 | 13 | 10 | 3 | 8 | 5 | 16 | 23 | 43 |
| Total | 39 | 23 | 16 | 19 | 20 | 40 | 43 | 56 |
DF=disease free; DOD=dead of disease; NED=no evidence of disease; DFS=disease-free survival; OAS=overall survival.